Cat Cardiomyopathy Welfare and Long-term Management

Feline cardiomyopathy — particularly hypertrophic cardiomyopathy (HCM) — is the most common heart disease in cats and can cause sudden death, congestive heart failure, or aortic thromboembolism.

Key Facts

HCM affects an estimated 15% of apparently healthy cats and up to 30% of Maine Coons
The disease causes thickening of the heart muscle that reduces filling capacity and increases arrhythmia risk
Aortic thromboembolism (ATE) occurs when clots form in the enlarged heart and lodge in the aorta, causing sudden paralysis
Many cats with HCM remain asymptomatic for years before developing heart failure or ATE
Echocardiography is the only reliable method to detect and grade HCM

Welfare Considerations

Feline HCM causes significant welfare problems across its spectrum. Cats with advanced HCM experience respiratory distress from fluid accumulation in the chest. Aortic thromboembolism causes sudden, catastrophic pain — affected cats cry out, lose use of their hindlimbs, and experience extreme distress. ATE carries a very poor prognosis and euthanasia is often the most humane response. The silent early phase of HCM, during which no signs are apparent, makes welfare monitoring challenging. Anti-clotting medication in high-risk cats reduces ATE risk, representing an important welfare intervention.

What You Can Do

Have cats screened by echocardiography if they are Maine Coons or other breeds predisposed to HCM
Discuss anti-platelet therapy with your veterinarian for cats with moderate to severe HCM
Monitor cats with HCM for early signs of heart failure including increased respiratory rate and effort
Seek emergency veterinary care immediately if your cat shows sudden hindlimb weakness or pain